Market Cap 9.80B
Revenue (ttm) 1.22B
Net Income (ttm) 73.40M
EPS (ttm) N/A
PE Ratio 35.89
Forward PE 35.23
Profit Margin 6.02%
Debt to Equity Ratio 0.18
Volume 3,492,900
Avg Vol 2,502,106
Day's Range N/A - N/A
Shares Out 155.69M
Stochastic %K 93%
Beta 1.48
Analysts Strong Sell
Price Target $66.50

Company Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth f...

Industry: Biotechnology
Sector: Healthcare
Phone: 612 379 8854
Fax: 612 656 4400
Address:
614 McKinley Place N.E., Minneapolis, United States
SuperGreenToday
SuperGreenToday Oct. 3 at 7:48 PM
$TECH Share Price: $63.12 Contract Selected: Apr 17, 2026 $65 Calls Buy Zone: $6.54 – $8.09 Target Zone: $10.82 – $13.23 Potential Upside: 56% ROI Time to Expiration: 195 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Fizz26
Fizz26 Oct. 3 at 4:07 PM
$DJIA $TECH keeps moving
0 · Reply
StockAutoPro
StockAutoPro Oct. 2 at 7:37 PM
$TECH: Buy target $58.75 Sell target $63.79 Strong earnings report suggests potential growth for this leading social media platform.
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 2 at 7:23 PM
🏛️ 🚀 $TECH up ⬆️21.65% since our entry $51.63 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
Fizz26
Fizz26 Oct. 2 at 5:39 PM
$DJIA $TECH flying!!!
0 · Reply
Estimize
Estimize Oct. 2 at 11:00 AM
Wall St is expecting 0.42 EPS for $TECH Q1 [Reporting 11/04 BMO] http://www.estimize.com/intro/tech?chart=historical&metric_name=eps&utm_co
0 · Reply
shitzushimazu
shitzushimazu Oct. 2 at 1:03 AM
$TECH holy shit techne about time
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 1 at 5:01 PM
🏛️ 🚀 $TECH up ⬆️13.23% since our entry $51.63 on Sep 26, 2025 👉 FREE TRIAL! Check bio. ALL signals Time stamped. NO B.S.!
0 · Reply
highnihilism
highnihilism Oct. 1 at 8:43 AM
$TECH Bio-Techne Trade Count: 25 | Total $: 6.4 K | 0.10 × 90-Day Avg $: 66.6 K | Call $: 4.8 K | Put $: 1.7 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PCB PCB Bancorp Trade Count: 3 | Total $: 4.8 K | 2.43 × 90-Day Avg $: 2 K | Call $: 4.8 K | Put $: 51 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $ATR Aptargroup Trade Count: 13 | Total $: 16.1 K | 0.62 × 90-Day Avg $: 26.1 K | Call $: 4.8 K | Put $: 11.4 K | % Single-Leg: 90% | % Multi-Leg: 10% | % Contingent: – $CMRE Costamare Trade Count: 24 | Total $: 32.6 K | 2.16 × 90-Day Avg $: 15.1 K | Call $: 4.7 K | Put $: 27.8 K | % Single-Leg: 65% | % Multi-Leg: 11% | % Contingent: 25%
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 30 at 5:33 PM
🎯 Target Hit 🏁 📨 Signal From Sep 26, 2025 🏛️ $TECH 💵 Entry: $51.6300 ✅ Exit: $52.6678 💰 P/L: +2.01% 👉 Check bio for full access
0 · Reply
Latest News on TECH
Bio-Techne to Present at Upcoming Investor Conferences

Aug 27, 2025, 7:00 AM EDT - 5 weeks ago

Bio-Techne to Present at Upcoming Investor Conferences


Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript

Aug 6, 2025, 12:52 PM EDT - 2 months ago

Bio-Techne Corporation (TECH) Q4 2025 Earnings Call Transcript


BIO-TECHNE DECLARES DIVIDEND

Aug 6, 2025, 6:30 AM EDT - 2 months ago

BIO-TECHNE DECLARES DIVIDEND


Bio-Techne Releases Fourth Quarter Fiscal 2025 Results

Aug 6, 2025, 6:30 AM EDT - 2 months ago

Bio-Techne Releases Fourth Quarter Fiscal 2025 Results


Bio-Techne Announces Exosome Diagnostics Divestiture

Aug 5, 2025, 4:30 PM EDT - 2 months ago

Bio-Techne Announces Exosome Diagnostics Divestiture


Bio-Techne to Present at Investor Conferences

May 29, 2025, 7:00 AM EDT - 4 months ago

Bio-Techne to Present at Investor Conferences


Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript

May 7, 2025, 10:38 AM EDT - 5 months ago

Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript


BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM

May 7, 2025, 6:30 AM EDT - 5 months ago

BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM


BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS

May 7, 2025, 6:30 AM EDT - 5 months ago

BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS


Bio-Techne Corporation (TECH) Q2 2025 Earnings Call Transcript

Feb 5, 2025, 2:24 PM EST - 8 months ago

Bio-Techne Corporation (TECH) Q2 2025 Earnings Call Transcript


Bio-Techne Declares Dividend

Feb 5, 2025, 6:30 AM EST - 8 months ago

Bio-Techne Declares Dividend


Bio-Techne Releases Second Quarter Fiscal 2025 Results

Feb 5, 2025, 6:30 AM EST - 8 months ago

Bio-Techne Releases Second Quarter Fiscal 2025 Results


Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors

Feb 4, 2025, 7:00 AM EST - 8 months ago

Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors


SuperGreenToday
SuperGreenToday Oct. 3 at 7:48 PM
$TECH Share Price: $63.12 Contract Selected: Apr 17, 2026 $65 Calls Buy Zone: $6.54 – $8.09 Target Zone: $10.82 – $13.23 Potential Upside: 56% ROI Time to Expiration: 195 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Fizz26
Fizz26 Oct. 3 at 4:07 PM
$DJIA $TECH keeps moving
0 · Reply
StockAutoPro
StockAutoPro Oct. 2 at 7:37 PM
$TECH: Buy target $58.75 Sell target $63.79 Strong earnings report suggests potential growth for this leading social media platform.
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 2 at 7:23 PM
🏛️ 🚀 $TECH up ⬆️21.65% since our entry $51.63 on Sep 26, 2025 👉 FREE TRIAL! spymyqqq.com/join/ Time-stamped signals. NO B.S.!
0 · Reply
Fizz26
Fizz26 Oct. 2 at 5:39 PM
$DJIA $TECH flying!!!
0 · Reply
Estimize
Estimize Oct. 2 at 11:00 AM
Wall St is expecting 0.42 EPS for $TECH Q1 [Reporting 11/04 BMO] http://www.estimize.com/intro/tech?chart=historical&metric_name=eps&utm_co
0 · Reply
shitzushimazu
shitzushimazu Oct. 2 at 1:03 AM
$TECH holy shit techne about time
0 · Reply
SPYmyQQQ
SPYmyQQQ Oct. 1 at 5:01 PM
🏛️ 🚀 $TECH up ⬆️13.23% since our entry $51.63 on Sep 26, 2025 👉 FREE TRIAL! Check bio. ALL signals Time stamped. NO B.S.!
0 · Reply
highnihilism
highnihilism Oct. 1 at 8:43 AM
$TECH Bio-Techne Trade Count: 25 | Total $: 6.4 K | 0.10 × 90-Day Avg $: 66.6 K | Call $: 4.8 K | Put $: 1.7 K | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $PCB PCB Bancorp Trade Count: 3 | Total $: 4.8 K | 2.43 × 90-Day Avg $: 2 K | Call $: 4.8 K | Put $: 51 | % Single-Leg: 100% | % Multi-Leg: 0% | % Contingent: – $ATR Aptargroup Trade Count: 13 | Total $: 16.1 K | 0.62 × 90-Day Avg $: 26.1 K | Call $: 4.8 K | Put $: 11.4 K | % Single-Leg: 90% | % Multi-Leg: 10% | % Contingent: – $CMRE Costamare Trade Count: 24 | Total $: 32.6 K | 2.16 × 90-Day Avg $: 15.1 K | Call $: 4.7 K | Put $: 27.8 K | % Single-Leg: 65% | % Multi-Leg: 11% | % Contingent: 25%
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 30 at 5:33 PM
🎯 Target Hit 🏁 📨 Signal From Sep 26, 2025 🏛️ $TECH 💵 Entry: $51.6300 ✅ Exit: $52.6678 💰 P/L: +2.01% 👉 Check bio for full access
0 · Reply
highnihilism
highnihilism Sep. 29 at 6:28 PM
S&P MidCap 400 (Health Care) → $PEN Penumbra $PRGO Perrigo $SRPT Sarepta Therapeutics $STE Steris $TECH Bio-Techne
0 · Reply
ZacksResearch
ZacksResearch Sep. 29 at 1:45 PM
$TECH unveils spatial biology advancements — will it spark a stock rally? 🌐 Bio-Techne's RNAscope & COMET innovations could boost clinical workflows, while its 3.9% earnings yield stands strong against an industry at -21.1%. However, $TECH holds a Zacks Rank #4 (Sell), so tread carefully. Discover the full story here 👉 https://www.zacks.com/stock/news/2758627/bio-techne-stock-climbs-on-advances-in-spatial-biology-solutions?cid=sm-stocktwits-2-2758627-body-14445&ADID=SYND_STOCKTWITS_TWEET_2_2758627_BODY_14445
0 · Reply
ZacksResearch
ZacksResearch Sep. 29 at 12:45 PM
$TECH on the move 🚀 — spatial biology gains are driving the stock higher. Advances in RNAscope and COMET are highlighting new roles in lymphoid malignancy diagnostics, giving fresh momentum to the story. Full breakdown here 👉 https://www.zacks.com/stock/news/2758627/bio-techne-stock-climbs-on-advances-in-spatial-biology-solutions?cid=sm-stocktwits-2-2758627-teaser-14444&ADID=SYND_STOCKTWITS_TWEET_2_2758627_TEASER_14444
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 26 at 3:02 PM
🚀 New Signal ✅ 🏛️ $TECH 🗓️ Sep 26, 2025 💵 Entry: $51.63 🎯 Target (Opt.): $52.67 (+2.01%) 👉 Check bio for full access
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 26 at 6:57 AM
Enter: $TECH OCT 17 2025 $55 CALLS Buy in Price: $0.92 - $1.35 Take Profit: $1.22 Stop Bleeding: $0.81 ROI Potential: 33% Exit Within: 148 Minutes https://moneygroup.us/alerts
0 · Reply
rwol9999
rwol9999 Sep. 25 at 2:20 PM
$FCX FCX had to move my funds to $TECH. Guess I will come back when they get this open again. very bullish on copper
0 · Reply
highnihilism
highnihilism Sep. 24 at 7:13 PM
Russell 2000 (Healthcare) → $SGEN Seagen $SGRY Surgery Partners $STAA STAAR Surgical $TECH Bio-Techne $THC Tenet Healthcare
0 · Reply
highnihilism
highnihilism Sep. 24 at 12:35 PM
Russell 2000 (Healthcare) → $SGEN Seagen $SGRY Surgery Partners $STAA STAAR Surgical $TECH Bio-Techne $THC Tenet Healthcare
0 · Reply
BillionerOfKing
BillionerOfKing Sep. 23 at 12:56 PM
$TECH Current Stock Price: $53.05 Contracts to trade: $55 TECH Oct 17 2025 Call Entry: $1.36 Exit: $2.40 ROI: 77% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Investogainerresearch
Investogainerresearch Sep. 22 at 5:48 PM
$TECHM.NSE $IT Share की बिक्री के बाद TECHM 100-दिन के EMA के नीचे गिरा; अमेरिकी नीति से बाजार प्रभावित Technical Analysis (Daily Chart) $TECH Mahindra saw a sharp decline today, closing near ₹1505 after a high of ₹1509. The $STOCK broke below its short-term 20 and 50-day EMAs, with bearish momentum confirmed by a falling RSI (around 47). Parabolic SAR dots above recent candles signal a negative bias, and MACD is declining, highlighting weak trend strength. Price failed to sustain above its 100-day and 200-day EMA, confirming resistance near ₹1550, with immediate support at ₹1490–1470 on daily charts. Fundamental Analysis Recent quarterly results showed a YoY PAT jump of 34% and operating margin improvement, but sales and consolidated profit fell sequentially. $TECH Mahindra presently has a PE of ~33, EV/EBITDA of 19+ (overvalued compared to peers), and ROE near 15.5%, but operating profit growth was just 6.59% per year (five years). Debt-to-equity (0.15) is low, but profit margins and EPS have weakened recently, signaling fundamental challenges. The $COMPANY remains a strong IT player but faces pricing and margin pressures in a tough macro environment. Micro & Macro View At the micro level, $TECH Mahindra's deal wins, portfolio expansion, and margin expansion project ("Project Fortis") are positives, but attrition and cost management remain concerns. Macro factors such as global IT spending, US visa policy changes, and currency headwinds continue to impact performance. The recent H-1B visa fee hike hit sector sentiment, pressuring Tech Mahindra and other IT names. Upcoming Events & Impact $TECH Mahindra is a Gold Sponsor at Fortinet Security Day 2025 and a premier sponsor at Oracle Health Summit in September, highlighting its focus on security and healthcare verticals. Ex-dividend date (Jul ’25, ₹30/share) already passed, no major near-term corporate action. Management aims for 15% margins by FY27. US macro policy changes (H-1B, tariffs) and client budgets are key risk factors for further movement. Disclaimer This analysis is prepared for educational purposes only and should not be considered as investment advice or a recommendation to buy/sell any stock. Investments in the stock market are subject to risks. Please consult a SEBI-registered financial advisor before making any investment decisions. Disclosure Investogainer Research is a SEBI Registered Research Analyst (Reg. No. INH000012856) and is listed with BSE (Code: 5845). Neither the analyst nor their family members hold any financial interest or beneficial ownership in the stock at the time of writing this report.
0 · Reply
BillionerOfKing
BillionerOfKing Sep. 22 at 3:23 PM
$TECH Current Stock Price: $53.07 Contracts to trade: $55 TECH Oct 17 2025 Call Entry: $1.50 Exit: $2.33 ROI: 55% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Sep. 19 at 4:52 PM
Enter: $TECH OCT 17 2025 $55 CALLS Buy in Price: $1.11 - $1.60 Take Profit: $2.04 Stop Bleeding: $0.98 ROI Potential: 84% Exit Within: 284 Minutes https://moneygroup.us/alerts
0 · Reply